Evaluation of the Clinical Performance of a Novel Chemiluminescent Immunoassay for Detection of Anticardiolipin and Anti-Beta2-Glycoprotein 1 Antibodies in the Diagnosis of Antiphospholipid Syndrome

Detection of antiphospholipid antibodies represents the first-line approach for diagnosis of antiphospholipid syndrome (APS). In this study, we evaluated the clinical performance of a novel chemiluminescence assay (CIA) in detection of IgG/IgM/IgA anti-cardiolipin (aCL) and IgG/IgM/IgA anti-β2 glyco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shulan, Wu, Ziyan, Li, Ping, Bai, Yina, Zhang, Fengchun, Li, Yongzhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Diagnostic Accuracy Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652825/
https://www.ncbi.nlm.nih.gov/pubmed/26579816
http://dx.doi.org/10.1097/MD.0000000000002059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652825/
https://www.ncbi.nlm.nih.gov/pubmed/26579816
http://dx.doi.org/10.1097/MD.0000000000002059

Ejemplares similares